Jazz outlines full survival data for lung cancer drug Zepzelca
A drug from Jazz Pharmaceuticals that has yet to read out confirmatory data in lung cancer succeeded in another Phase 3 trial, as the company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
